Skip to main content
DNA Labs India

COL6A2 Gene Myosclerosis, autosomal recessive NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

COL6A2 Gene Myosclerosis, autosomal recessive NGS Genetic Test

Short Name: COL6A2 Myosclerosis NGS

Also known as: COL6A2 Gene Mutation Testing, Myosclerosis Genetic Test, Collagen VI gene sequencing

COL6A2 Gene Myosclerosis, autosomal recessive NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports will be available within 3 to 4 weeks from sample receipt.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this NGS genetic test is to detect mutations in the COL6A2 gene that cause autosomal recessive myosclerosis. It is used to confirm a suspected diagnosis in symptomatic individuals, provide prognostic information based on the specific variant, identify carrier status for at-risk family members, and guide reproductive decisions. NGS technology allows high-throughput sequencing of all exons and splice sites of COL6A2 with high sensitivity and specificity, enabling accurate molecular diagnosis of this rare neuromuscular disorder.

Test Code
4387
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports will be available within 3 to 4 weeks from sample receipt.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. However, a genetic counseling session is mandatory before sample collection to draw a three-generation family pedigree and assess the appropriateness of the test. The patient should bring previous medical records, MRI/EMG reports, and information about affected and unaffected family members. If the patient is on anticoagulant therapy, the clinical team should be informed prior to blood draw.

Method: Peripheral blood draw or FTA card sample

Step 2

Laboratory Analysis

A peripheral blood sample (2-3 mL) will be collected in an EDTA tube by a trained phlebotomist. For FTA card samples, a drop of blood from a finger prick is placed on the designated card and allowed to air dry. The procedure is quick and minimally invasive. No fasting is required. For extracted DNA submission, a minimum of 2 µg of high-quality DNA is recommended and should be shipped on dry ice.

Step 3

Report Delivery

Blood samples should be transported to the laboratory at ambient temperature for EDTA samples or at room temperature for FTA cards. Samples should reach the laboratory within 48 hours for optimal DNA yield. No special dietary or activity restrictions apply after sample collection.

Timeline: Reports will be available within 3 to 4 weeks from sample receipt.

Patient Instructions

1
Before the Test:Clinical History of Patient who is going for COL6A2 Gene Myosclerosis, autosomal recessive NGS Genetic Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL6A2 Gene Myosclerosis, autosomal recessive Disease Neurological Disorders.
2
During the Test:A trained phlebotomist will collect the blood sample. The patient may be asked to roll up a sleeve and the procedure takes less than 5 minutes. There is no pain except a brief needle pinch.
3
After the Test:After sample submission, no specific care instructions are needed. The laboratory will process the sample and provide reports via the chosen delivery method. Genetic counseling will be arranged after results are available to interpret the findings and discuss management.

About This Test

Who Should Get This Test

The primary purpose of this NGS genetic test is to detect mutations in the COL6A2 gene that cause autosomal recessive myosclerosis. It is used to confirm a suspected diagnosis in symptomatic individuals, provide prognostic information based on the specific variant, identify carrier status for at-risk family members, and guide reproductive decisions. NGS technology allows high-throughput sequencing of all exons and splice sites of COL6A2 with high sensitivity and specificity, enabling accurate molecular diagnosis of this rare neuromuscular disorder.

How to Prepare

  • Use EDTA vacutainer for whole blood collection
  • For FTA card, ensure the blood spot is fully saturated and air-dried for 30 minutes
  • Do not refrigerate FTA cards
  • Label sample with patient name, date of birth, and date of collection
  • Ship sample in provided biohazard bag with absorbent material

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"Genetic counseling is strongly recommended before and after testing to interpret results and discuss implications for family members."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 mL
ContainerEDTA tube or FTA card
Collection MethodPeripheral blood draw or FTA card sample

Sample Stability

EDTA whole blood at room temperature48 hours
EDTA whole blood at 2-8°C72 hours
FTA card at room temperature1 year
Extracted DNA at -20°C6 months
Sample Rejection Criteria:
  • Hemolyzed or clotted blood samples
  • Insufficient blood volume
  • FTA card with too little blood or contaminated
  • Incorrect label or secondary sample
  • Sample shipped in leaky packaging

Understanding Your Results

The clinical interpretation of COL6A2 gene variants is guided by the American College of Medical Genetics and Genomics (ACMG) standards. The report includes the identified variants, their classification, and the predicted impact on protein function. A homozygous pathogenic variant confirms a diagnosis of autosomal recessive myosclerosis, while a heterozygous variant indicates carrier status.
📊

Pathogenic variant in both alleles

Confirms diagnosis of autosomal recessive myosclerosis; genetic counseling recommended.

📊

Pathogenic variant in one allele

Carrier status; no symptomatic disease expected, but 50% chance to pass variant to offspring.

📊

Likely pathogenic variant(s) in both alleles

Diagnostic with high confidence; functional studies may be needed in some cases.

📊

No pathogenic variant detected

Does not rule out myosclerosis; other genes or non-coding variants may be responsible.

📊

Variant of uncertain significance (VUS)

Current evidence insufficient for classification; further family segregation studies recommended.

⚠️ When to Consult a Doctor:

Consult a qualified geneticist or neurologist to discuss whether genetic testing is appropriate. A doctor may order this test if you or your child show signs of muscle weakness, joint stiffness, scoliosis, or unexplained delayed motor milestones. It is also indicated when there is a known family history of myosclerosis or COL6A2 variants. Before undergoing the test, a genetic counseling session is necessary to understand the benefits, limitations, and potential outcomes.

Limitations

  • NGS may not reliably detect large deletions/duplications unless additional CNV analysis is performed
  • Variants in non-coding regulatory regions are not fully evaluated
  • Mutations in genes other than COL6A2 that cause similar phenotypes may not be identified
  • Results should be interpreted in conjunction with clinical findings and family history
  • Variant of uncertain significance may require further analysis or family segregation studies

Risks & Considerations

  • No significant physical risks associated with blood draw except minor bruising
  • No pharmacological or medical risks
  • Psychological impact of receiving a diagnostic result
  • Potential for uncertain genetic result that may require additional testing

Interfering Factors

  • Contamination of sample with another person's DNA
  • Poor quality DNA due to hemolysis or improper storage
  • Low sequencing depth at specific GC-rich regions
  • Large gene rearrangements not detectable by standard NGS panel

Compare With Similar Tests

TestCOL6A2 Gene Myosclerosis, autosomal recessive NGS Genetic Test
ComparisonCOL6A2 Gene Myosclerosis, autosomal recessive NGS Genetic TestNGS full-gene sequencing covers all exons and splice sites with high accuracy, cost-effective, and faster than Sanger sequencing.Sequences COL6A1, COL6A2, and COL6A3 in a single assay; more comprehensive for related myopathies.Analyzes all known gene coding regions; broader scope, higher probability of unsolicited findings.

Frequently Asked Questions

What is myosclerosis?
Myosclerosis is a rare autosomal recessive genetic disorder caused by mutations in COL6A2 gene. It leads to muscle weakness, joint stiffness, scoliosis, and respiratory problems.
How is myosclerosis inherited?
It is inherited in an autosomal recessive manner, meaning both parents must carry a mutated gene copy. Each child has a 25% chance of being affected.
What does this test detect?
This NGS test analyzes the COL6A2 gene for disease-causing variants that can lead to myosclerosis.
Who should take this test?
Individuals showing symptoms of myosclerosis, or those with a family history of COL6A2 mutations, or carriers who want to know their status.
What sample is needed?
A simple blood sample placed in an EDTA tube, or a few drops of blood on an FTA card, or extracted DNA can be submitted for analysis.
Is fasting required before sample collection?
No, fasting is not required for this genetic test.
How long does the test take?
Reports are generally provided within 3 to 4 weeks after the sample reaches the laboratory.
What is the cost of the test?
The test costs INR 20,000 at DNA Labs India. We also provide free home sample collection for online bookings.
What do results mean?
A pathogenic variant in both copies of the gene confirms the diagnosis of myosclerosis, while a single mutation indicates carrier status.
Can this test detect carriers?
Yes, the test can identify heterozygous carriers who have one mutated allele and are not affected.
Does DNA Labs India provide genetic counseling?
Yes, a genetic counselling session is included with the test; our counselor will explain the pedigree and result implications.
Is the test available all over India?
Yes, we offer free home sample collection in more than 200 Indian cities, including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, and Kolkata.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.